VASOOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
VASO Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.29+0.00 (+0.06%)
Close on Oct 19, 2026
- Market cap
- $51.17M
- P/E (TTM)
- 29.0
- Dividend yield
- –
Share price
+$0.1737 (+149.1%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
VASO Corp grew revenue 3.4% to $80.22M over the twelve months to Jun 30, 2026.
Revenue
$80.22M
+3.4% vs. a year earlier
Operating income
-$1.61M
TTM Q2 2026
EPS, diluted
$0.01
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $51.17M
- P/E ratio
- 29.0
- Price to sales
- 0.64
- Price to book
- 1.75
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $80.22M
- Net income
- $2.50M
- EPS, diluted
- $0.01
- Book value per share
- $0.17
- Diluted shares
- 176M
Fifteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
$80.22M+3.4% YoY
Gross profit
$51.98M+7.7% YoY
Operating income
-$1.61M
Net income
$2.50M
EPS, diluted
$0.01
Free cash flow
–
Reported periodTrailing twelve months